A poised fragment library enables rapid synthetic expansion yielding the first reported inhibitors of PHIP(2), an atypical bromodomain

被引:100
作者
Cox, Oakley B. [1 ,2 ,3 ]
Krojer, Tobias [1 ]
Collins, Patrick [3 ]
Monteiro, Octovia [1 ,2 ]
Talon, Romain [1 ]
Bradley, Anthony [1 ]
Fedorov, Oleg [1 ,2 ]
Amin, Jahangir [4 ]
Marsden, Brian D. [1 ,5 ]
Spencer, John [4 ]
von Delft, Frank [1 ,3 ,6 ]
Brennan, Paul E. [1 ,2 ]
机构
[1] Univ Oxford, SGC, Oxford OX3 7DQ, England
[2] Univ Oxford, Nuffield Dept Med, TDI, Oxford OX3 7FZ, England
[3] DLS, Harwell Sci & Innovat Campus, Didcot OX11 0DE, Oxon, England
[4] Univ Sussex, Dept Chem, Sch Life Sci, Brighton BN1 9QJ, E Sussex, England
[5] Univ Oxford, Kennedy Inst Rheumatol, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Roosevelt Dr, Oxford OX3 7FY, England
[6] Univ Johannesburg, Dept Biochem, ZA-2006 Aukland Pk, South Africa
基金
加拿大创新基金会; 巴西圣保罗研究基金会; 英国惠康基金;
关键词
DRUG DISCOVERY; CHEMICAL PROBE; DESIGN; OPTIMIZATION; IDENTIFICATION; RECOGNITION; LIGANDS; BAZ2B;
D O I
10.1039/c5sc03115j
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Research into the chemical biology of bromodomains has been driven by the development of acetyl-lysine mimetics. The ligands are typically anchored by binding to a highly conserved asparagine residue. Atypical bromodomains, for which the asparagine is mutated, have thus far proven elusive targets, including PHIP(2) whose parent protein, PHIP, has been linked to disease progression in diabetes and cancers. The PHIP(2) binding site contains a threonine in place of asparagine, and solution screening have yielded no convincing hits. We have overcome this hurdle by combining the sensitivity of X-ray crystallography, used as the primary fragment screen, with a strategy for rapid follow-up synthesis using a chemically-poised fragment library, which allows hits to be readily modified by parallel chemistry both peripherally and in the core. Our approach yielded the first reported hit compounds of PHIP(2) with measurable IC50 values by an AlphaScreen competition assay. The follow-up libraries of four poised fragment hits improved potency into the sub-mM range while showing good ligand efficiency and detailed structural data.
引用
收藏
页码:2322 / 2330
页数:9
相关论文
共 38 条
  • [1] Small Molecule Inhibitors of Bromodomain-Acetyl-lysine Interactions
    Brand, Michael
    Measures, Angelina M.
    Wilson, Brian G.
    Cortopassi, Wilian A.
    Alexander, Rikki
    Hoess, Matthias
    Hewings, David S.
    Rooney, Timothy P. C.
    Paton, Robert S.
    Conway, Stuart J.
    [J]. ACS CHEMICAL BIOLOGY, 2015, 10 (01) : 22 - 39
  • [2] Structure-based approaches towards identification of fragments for the low-druggability ATAD2 bromodomain
    Chaikuad, Apirat
    Petros, Andrew M.
    Fedorov, Oleg
    Xu, Jing
    Knapp, Stefan
    [J]. MEDCHEMCOMM, 2014, 5 (12) : 1843 - 1848
  • [3] Lessons for fragment library design: analysis of output from multiple screening campaigns
    Chen, I-Jen
    Hubbard, Roderick E.
    [J]. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2009, 23 (08) : 603 - 620
  • [4] Discovery and Characterization of GSK2801, a Selective Chemical Probe for the Bromodomains BAZ2A and BAZ2B
    Chen, Peiling
    Chaikuad, Apirat
    Bamborough, Paul
    Bantscheff, Marcus
    Bountra, Chas
    Chung, Chun-wa
    Fedorov, Oleg
    Grandi, Paola
    Jung, David
    Lesniak, Robert
    Lindon, Matthew
    Mueller, Susanne
    Philpott, Martin
    Prinjha, Rab
    Rogers, Catherine
    Selenski, Carolyn
    Tallant, Cynthia
    Werner, Thilo
    Willson, Timothy M.
    Knapp, Stefan
    Drewry, David H.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (04) : 1410 - 1424
  • [5] Fragment-Based Discovery of Bromodomain Inhibitors Part 1: Inhibitor Binding Modes and Implications for Lead Discovery
    Chung, Chun-wa
    Dean, Anthony W.
    Woolven, James M.
    Bamborough, Paul
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (02) : 576 - 586
  • [6] LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain Inhibitor
    Clark, Peter G. K.
    Vieira, Lucas C. C.
    Tallant, Cynthia
    Fedorov, Oleg
    Singleton, Dean C.
    Rogers, Catherine M.
    Monteiro, Octovia P.
    Bennett, James M.
    Baronio, Roberta
    Mueller, Susanne
    Daniels, Danette L.
    Mendez, Jacqui
    Knapp, Stefan
    Brennan, Paul E.
    Dixon, Darren J.
    [J]. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2015, 54 (21) : 6217 - 6221
  • [7] Pleckstrin homology domain-interacting protein (PHIP) as a marker and mediator of melanoma metastasis
    De Semir, David
    Nosrati, Mehdi
    Bezrookove, Vladimir
    Dar, Altaf A.
    Federman, Scot
    Bienvenu, Geraldine
    Venna, Suraj
    Rangel, Javier
    Climent, Joan
    Tamgueney, Tanja M. Meyer
    Thummala, Suresh
    Tong, Schuyler
    Leong, Stanley P. L.
    Haqq, Chris
    Billings, Paul
    Miller, James R., III
    Sagebiel, Richard W.
    Debs, Robert
    Kashani-Sabet, Mohammed
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (18) : 7067 - 7072
  • [8] Delft F. v., FULL DETAILS D UNPUB
  • [9] Structure Enabled Design of BAZ2-ICR, A Chemical Probe Targeting the Bromodomains of BAZ2A and BAZ2B
    Drouin, Ludovic
    McGrath, Sally
    Vidler, Lewis R.
    Chaikuad, Apirat
    Monteiro, Octovia
    Tallant, Cynthia
    Philpott, Martin
    Rogers, Catherine
    Fedorov, Oleg
    Liu, Manjuan
    Akhtar, Wasim
    Hayes, Angela
    Raynaud, Florence
    Mueller, Susanne
    Knapp, Stefan
    Hoelder, Swen
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (05) : 2553 - 2559
  • [10] [1,2,4]Triazolo[4,3-a]phthalazines: Inhibitors of Diverse Bromodomains
    Fedorov, Oleg
    Lingard, Hannah
    Wells, Chris
    Monteiro, Octovia P.
    Picaud, Sarah
    Keates, Tracy
    Yapp, Clarence
    Philpott, Martin
    Martin, Sarah J.
    Felletar, Ildiko
    Marsden, Brian D.
    Filippakopoulos, Panagis
    Mueller, Susanne
    Knapp, Stefan
    Brennan, Paul E.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (02) : 462 - 476